RxDoctor Payments Data

Tori Lightner

Psychiatric/Mental Health · Lewistown, PANPI 1134701808

Payments from drug & device makers

$5,669in general payments, 2019–2025

Across 412 payments — averaging $13.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$990
  • Otsuka America Pharmaceutical, Inc.$882
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$725
  • Johnson & Johnson$502
  • Teva Pharmaceuticals USA, Inc.$433
  • Lundbeck LLC$395
  • plus $2K from 9 others

What the payments were for

  • Food & beverage$5,55798%
  • Education$1112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,669 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$11,197
Medicare patients
34
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate17$131,745
Austedo XrDeutetrabenazine20$97,619
Invega SustennaPaliperidone Palmitate25$71,012
VraylarCariprazine Hcl23$43,930
FetzimaLevomilnacipran Hcl21$9,902
Aripiprazole61$4,536
Trazodone Hcl144$1,270
Buspirone Hcl90$911
Venlafaxine Hcl ErVenlafaxine Hcl84$784
Bupropion Hcl SrBupropion Hcl60$705
Lamotrigine61$693
Quetiapine Fumarate96$655
Clonazepam93$637
Risperidone71$529
Bupropion XlBupropion Hcl46$473

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$331$131,74517 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$433$97,61920 claims
Johnson & JohnsonInvega Sustenna$502$71,01225 claims
AbbVieVraylar, Fetzima$990$53,83244 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Lewistown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →